Recent Finacing
Recent Raise
Hornet Therapeutics is a London-based biotech developing EBV-targeted therapies, advancing HTX-201, an IDO‑1 inhibitor, toward phase 1/2 trials to prevent EBV-driven PTLD in transplant recipients.
Focus Areas
Recent Investors
Funding round
Investor